SZSE Ticker: 300347

Hangzhou Tigermed Consulting Co., Ltd.

杭州泰格医药科技股份有限公司

泰格医药

TIGERMED

Listing Date: 2012-08-17

Board: GEM

Industry Classification: Public Health

Hillhouse has won an IPO, laid out a pharmaceutical SMO, with a market value of over 4 billion – yqqlm

Hillhouse has won an IPO, laid out a pharmaceutical SMO, with a market value of over 4 billion – yqqlm

JiCuiYaoKang breaks through the science and technology innovation board: CXO continues to be hot, is experimental mice a good business? Internet channel Rongyi Information Network

The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net

JiCuiYaoKang breaks through the science and technology board: CXO continues to be hot, is experimental mice a good business? internet channel

JiCuiYaoKang breaks through the science and technology board: CXO continues to be hot, is experimental mice a good business? Internet channel Rongyi Information Network

JiCuiYaoKang breaks through the science and technology board: CXO continues to be hot, is experimental mice a good business? internet channel

In 2021, 70% of listed companies’ securities investment will be profitable: 233 companies earn more than 100 million yuan, but 196 companies withdraw – yqqlm

The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

The pharmaceutical and biological industry has a net outflow of 2.855 billion yuan today, and the net outflow of 6 shares exceeds 100 million yuan.

List of Zhitong A Share Restriction and Lifting of the Ban on May 13 Equity Incentives_Sina Finance_Sina.com

[Express] 12 stocks facing selling pressure on Friday, 2.89 billion shares lifted CFi.CN Zhongcai Network

Changxin Healthcare Hybrid (LOF) C Net Worth Up 3.26% LOF

Morgan Stanley Health Industry Mixed C Net Worth Up 3.81%

China Universal CSI Precision Medicine Index (LOF) A Net Value Up 3.43% China Universal

Yinhua CSI Innovative Drug Industry ETF Net Value Up 3.08%

E Fund CSI Innovative Drug Industry ETF Net Value Up 3.06% E Fund

Celestica Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Selection 50ETF Net Value Up 3.65% Celestica

GF China Securities Innovative Drug Industry ETF Net Value Up 3.12%

Cathay CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry ETF Net Value Up 3.23% Cathay Pacific

ICBC Credit Suisse CSI Innovative Drug Industry ETF Net Value Up 3.07% ICBC Credit Suisse

Want to see more data? Registered subscribers can see all the data.